WebFusix Biotech GmbH was delighted to be selected as one of the top 10 female-led start-ups to pitch at the Business Angels Netzwerk Deutschland e.V… Beliebt bei Prof. Dr. med. Oliver Ebert Newsweek's World's Best Hospitals 2024 ranking lists our university hospital Klinikum rechts der Isar 20th in the world. 🥳 #ranking #medicine… http://emergingbiotalk.com/biotech-bootcamp-winner-fusix-biotech-gmbh-in-interview/

Munich scores at the Science4Life Business Plan Competition 2024

WebFusix Biotech GmbH Biotechnology Research University spin-out commercializing a novel fusion-based oncolytic viro-immunotherapy Follow About us We are a spin-out from the Technical University... WebSep 27, 2024 · Biotech Bootcamp winner Fusix Biotech GmbH in interview. September 27, 2024 / by Tanja Knoll. The Biotech Bootcamp, which is run in partnership with SmiLe and BioM, provides valuable support in a group or one-on-one setting, with a mix of live and recorded lectures, expert Q&As, panel discussions, personalized mentorship, and pitch … shri ram foundation pre school delhi

m4 Award 2024: 2.5 million euros for the fight against cancer

WebJan 10, 2024 · FUSIX Biotech, Jennifer Altomonte: A TUM spin-off developing a “best-in-class” oncolytic virus platform to treat solid tumors Galimedix, Alexander Gebauer: Breakthrough therapy in Alzheimer´s disease: Small molecule GAL-201 for cognitive improvement and neuroprotection WebThe Munich-based start-up Fusix Biotech took third place and aims to offer patients with difficult-to-treat cancers safe and effective immunotherapeutic approaches with the help of its platform technology. WebFounded in 2024 "Our mission is to develop a pipeline of best-in-class oncolytic immunotherapeutics that are highly effective in treating cancer patients with solid cancers. At Seneca Therapeutics, we believe a cure for cancer is within our lifetime and we are working with urgency to see this promising possibility become a reality. shriram gateway accenture